Procalcitonin vs C-reactive protein in early detection of intrauterine infection in premature rupture of membranes and neonatal infections by Vesna Elveđi Gašparović et al.
54 www.signavitae.com
Procalcitonin vs C-reactive 
protein in early detection 
of intrauterine infection 
in premature rupture of 
membranes and neonatal 
infections
ABSTRACT
At any time during pregnancy intrauterine infection is an important risk factor for neonatal sepsis and is a frequent cause 
of mortality and morbidity in newborn infants. The aim of this study was to consider the patterns of procalcitonin (PCT) res-
ponse in normal pregnancy and in pregnancies complicated with a premature rupture of the membranes, to compare the 
results of PCT with those of C-reactive protein (CRP) and to assess their diagnostic accuracy both to mothers and neonates. 
120 mothers with singleton pregnancies were enrolled in this study. 60 pregnancies were complicated with a premature 
rupture of membranes, and 60 were control pregnancies. We analyzed PCT and CRP values, clinical chorioamnionitis, neo-
natal infection and other neonatal outcomes in both groups. We found significantly higher maternal serum concentrations 
of PCT and CRP in the Study group. Regarding our results, both markers are predictive for chorioamnionitis and neonatal 
infections, with almost similar significance. 
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Introduction
The diagnosis of early onset neonatal 
infection remains one of the greatest 
challenges in perinatal medicine. At 
birth the diagnosis must be based on 
the history of the pregnancy and take 
into account a number of risk factors, 
such as preterm premature rupture of 
membranes, along with (usually late to 
be recognised) subclinical intrauterine 
infection. Early onset neonatal infec-
tion is associated with an ascending 
infection from the cervix, and the intact 
membranes during pregnancy act as 
an effective barrier against infection of 
the amniotic fluid. (1) Intrauterine infec-
tion at any time during pregnancy is an 
important risk factor for neonatal sepsis 
and is a frequent cause of mortality and 
morbidity in newborn infants. 
If promptly initiated, antibiotic therapy 
can reduce its sequelae and impro-
ve the prognosis. However, the num-
ber of tests that obstetrician can rely 
on for the early diagnosis of infection 
is quite limited. Culture tests are not 
immune from the risk of contamination 
and the measurement of interleukins in 
the amniotic fluid and maternal blood 
serum is not yet routine. The useful-
ness of procalcitonin (PCT) as a dia-
gnostic tool of maternal-fetal infections 
is currently being evaluated, and the 
results of recent PCT studies regarding 
its usefulness for early diagnosis of 
neonatal sepsis have produced varying 
results. (2)
 The aim of this study was to consi-
der the patterns of PCT response in 
normal pregnancy and in pregnancies 
complicated with premature rupture of 
the membranes and to compare the 
results of PCT with those of C-reactive 
protein (CRP) and to assess their dia-
gnostic accuracy both to mothers and 
neonates.
Materials and methods
A total of 120 mothers with singleton 
pregnancies were enrolled in this study. 
60 pregnancies were complicated with 
the premature rupture of membranes, 
and 60 were control pregnancies. The 
study included pregnancies that ended 
as premature and term deliveries. Pre-
gnancies with congenital fetal malfor-
mations were excluded from the study.
Clinical chorioamnionitis was diagno-
sed when maternal temperature was 
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≥38°C, leukocytosis >15.000x109/L, 
maternal (>100 beats/min) and fetal 
tachycardia (>160 beats/min). (3)
Early neonatal onset bacterial infecti-
on was recognized during the first 48 
hours of life based on maternal findings 
and the presence of clinical signs in the 
neonate: respiratory (apnea, tachypnea 
>60/min, high ventilator settings or oxy-
gen), cardiovascular (hypotension, poor 
peripheral perfusion, tachy/bradicar-
dia), neurological (seizures, hypotonia), 
skin colour (pallor, cyanosis, jaundice) 
and positive blood culture. (3) 
An immunoluminometric assay for the 
measurement of serum PCT concentra-
tion was performed with a Brahms KRYP-
TOR kit. The lowest detection limit of PCT 
using this method was 0.1 ng/ml.
All values are expressed as mean valu-
es. Statistical analyses were conducted 
using the non-parametric Mann Whitney 
test. Receiver operating characteristics 
(ROC) curves were used to determinate 
the diagnostic validity for predicting 
clinical chorioamnionitis and neonatal 
infections. Results were considered 
statistically significant at p< 0.05.
Results
We analysed 60 singleton pregnancies 
with premature rupture of membranes 
(PROM) as the Study group, and 60 sin-
gleton pregnancies without PROM as the 
Control group. We found a significantly 
lower gestational age (p=0.20), birth 
weight (p=0.27), and Apgar score in the 
first (p=0.48) and fifth minute (p=0.27) 
in the Study group. The incidence of 
clinical chorioamnionitis and neonatal 
infection was significantly higher in the 
Study group (p<0.001 and p=0.006). 
Neonates from the Study group had 
an almost four fold higher rate of NICU 
admission compared to neonates from 
the Control group (p=0.003). There was 
a significantly higher use of antibiotics 
during pregnancy in the Study group as 
well (p<0.001).
We found significantly higher maternal 
serum concentrations of PCT and CRP 
in the Study group.
The aim of this study was also to asses 
and to compare the diagnostic accu-
racy of PCT with those of CRP in the 
AUC CRP =0.79; best cut-off: > 7 mg/l;  83.3%sensitivity,  68.7% specificity 
AUC PCT =0.757;  best cut-off 0.053ng/l;  69% sensitivity,  73.6% specificity
AUC CRP/PCT, p= 0.0345
AUC, area under the curve
CRP, C reactive protein
PCT, procalcitonin
Figure 2. Receiver operating characteristics (ROC) curves for maternal CRP 
and PCT in prediction of neonatal infections 
AUC CRP =0.789;  the best cut-off  > 7 mg/L; 82.8% sensitivity,  71.4%specificity
AUC  PCT= 0.749;  the best cut-off  0.053ng/L; 69% sensitivity, 73.6% specificity
AUC CRP/PCT, p= 0.3789
AUC, area under the curve
CRP, C reactive protein
PCT, procalcitonin
Figure 1. Receiver operating characteristics (ROC) curves for maternal CRP 
and PCT in prediction of chorioamnionitis; 
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prediction of chorioamnionitis (figure 1) 
and neonatal infection (figure 2).
Discussion
Sepsis is a condition that markedly influ-
ences mortality and morbidity in neona-
tal intensive care units. The main risk 
factors associated with neonatal sep-
sis are chorioamnionitis and preterm 
delivery. (4) One of the most important 
goals of recent research in the field 
of neonatology is to uncover a highly 
sensitive and specific method for early 
sepsis detection. Available laboratory 
tests lack the necessary sensitivity and 
specificity. This concentrates efforts on 
discovering new infection markers. (5) 
The pathogenesis of premature rupture 
of membranes resulting in preterm birth 
remains unknown, but many hypothe-
ses have been suggested. Intrauterine 
infection and subsequent inflamma-
tion may synergistically weaken the 
membranes because of the combined 
effects of microbia, host inflammatory 
cells and cytokine-regulated protease 
production. (6)   
The frequency of perinatal infections 
and other pregnancy complications is 
adversely correlated to the gestational 
age at delivery, and sepsis is a condi-
tion that markedly influences mortali-
ty and morbidity in neonatal intensive 
care units. (7) In patients with preterm 
rupture of membranes, the incidence 
of a severe neonatal morbidity rate was 
reported as 55% in patients with chori-
oamnionitis and 18% in those without. 
(3) In our study group, 38% of pati-
ents had chorioamnionitis, out of which 
30% had neonatal infection and 27% of 
those neonates were admitted to NICU. 
Clinical chorioamnionitis and antibio-
tics administration were significantly 
higher in the Study group (p<0.001) 
(table 1). The Study group had more 
preterm deliveries (p=0.143), and a 
lower Apgar score in first (p=0.048) 
and fifth (p=0.027) minute. 
Although the usefulness of procalcitonin 
(PCT) in clinical practice is increasing, 
there is still not enough data available to 
establish the role of procalcitonin in the 
patophysiology of pregnancy. 
In our study we found significantly 
higher PCT level in pregnancies com-
plicated with preterm rupture of mem-
branes (Study group) compared to 
the Control group (p<0.001) (table 2). 
The level of CRP in maternal serum in 
pregnancies complicated with preterm 
rupture of membranes was also eleva-
ted (p=0.025) (table 2). We therefore 
analysed the predictive value of CRP 
and PCT maternal levels for the diagno-
sis of chorioamnionitis (figure 1) and 
neonatal infection (figure 2). The AUC 
for both biomarkers showed relatively 
low, but still significant predictive valu-
es. We found AUC for CRP=0.78 and 
AUC for PCT=0.749 (figure1). 
The predictive value of CRP in chorioa-
mnionitis was no different when com-
pared to the predictive value of PCT 
(p= 0.3789) (figure 1). Results from a 
study by Trochez-Martinez et al. found 
no positive correlation between CRP 
and chorioamnionitis, but results from 
Jarc et al. were almost similar to ours. 
























































Apgar1 (points) (mean) 8.57 (0-10) 9.02 (0-10)
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NICU, neonatal intensive care unit
Table 2. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) 
concentrations
Study group ( n=60) 
Control group ( n=60) 
   p-value
PCT  ng/L 0.074±0.008 0.041±0.0023          < .001
CRP  mg/L 13.95±2.33 8.987±1.82 .025
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(8,9) Analysing the detection of neona-
tal infection, we found a significantly 
higher predictive value of CRP compa-
red to PCT (p = 0. 0345) (figure 2).
A meta-analysis of six studies confirmed 
that CRP does not predict histological 
chorioamnionitis reliably. (8) Some aut-
hors reported 96% specificity and 88% 
sensitivity for CRP>13mg/L10. Some 
authors have not confirmed these fin-
dings with even higher concentrations of 
CRP. Fiski et al. reported 50% sensitivity 
and 80% specificity in their study. (11) 
Our results confirm this latter finding that 
neither CRP nor PCT in maternal blood 
after preterm rupture of membranes offer 
a precise diagnosis for subclinical chori-
oamnionitis. Predictive values of mater-
nal PCT level for chorioamnionitis and 
neonatal infection, however, habe not 
been adequately studied yet. Popowski 
et al. found CRP to be a reliable predic-
tive factor of early neonatal sepsis in 
PROM at 34-37 weeks of gestation. (12) 
The clinical significance of this study 
remains questionable, since pregnancy 
is usually terminated after preterm pre-
mature rupture of membranes at or after 
34 weeks (through induction of labour or 
caesarean section).
Conclusion
Regarding our results, both markers 
are predictive for chorioamnionitis and 
neonatal infections, with almost simi-
lar significance. Future studies should 
focus on newer and potentially better 
diagnostic markers for the early diagno-
sis of chorioamnionitis and neonatal 
infection in pregnancies complicated 
with preterm rupture of membranes. 
Such markers would allow terminati-
on of pregnancy prior to a potentially 
adverse fetal outcome, but also assist 
in identifying cases in which prolonging 
pregnancy in beneficial.
